Neurochemical Research

Preface
pp. 977-977(1)
Author: Duff K.

Use of in Vivo Models to Study the Role of Cholesterol in the Etiology of Alzheimer's Disease
pp. 979-986(8)
Authors: Burns M.; Duff K.

In Vivo NMR Studies of Neurodegenerative Diseases in Transgenic and Rodent Models
pp. 987-1001(15)
Authors: Choi I-Y.; Lee S-P.; Guilfoyle D.N.; Helpern J.A.

Estrogen and Neurodegeneration
pp. 1003-1008(6)
Author: Gandy S.

Usefulness of Behavioral and Electrophysiological Studies in Transgenic Models of Alzheimer's Disease
pp. 1009-1015(7)
Authors: Sant'Angelo A.; Trinchese F.; Arancio O.

Amyloid-Beta Immunization in Alzheimer's Disease Transgenic Mouse Models and Wildtype Mice
pp. 1017-1027(11)
Authors: Lemere C.A.; Spooner E.T.; Leverone J.F.; Mori C.; Iglesias M.; Bloom J.K.; Seabrook T.J.

Learning and Memory Deficits in APP Transgenic Mouse Models of Amyloid Deposition
pp. 1029-1034(6)
Author: Morgan D.

Neuroprotective Mechanisms of Antiparkinsonian Dopamine D₂-Receptor Subfamily Agonists
pp. 1035-1040(6)
Authors: Kitamura Y.; Taniguchi T.; Shimohama S.; Akaike A.; Nomura Y.

Defective Neurofilament Transport in Mouse Models of Amyotrophic Lateral Sclerosis: A Review
pp. 1041-1047(7)
Authors: Rao M.V.; Nixon R.A.

APP Processing Enzymes (Secretases) as Therapeutic Targets: Insights from the Use of Transgenics (Tgs) and Transfected Cells
pp. 1049-1062(14)
Authors: Marks N.; Berg M.J.

Abstracts of Communications of the 45^th Annual Meeting of the Japanese Society for Neurochemistry
pp. 1063-1144(82)